End Cash: The amount of cash held by the company for the given period.
Profound Medical (PROF) had End Cash of $50.30M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$5.34M |
|
$-7.05M |
|
$1.50M |
|
$3.83M |
|
$13.36M |
|
$-8.02M |
|
$0.99M |
|
$-7.03M |
|
$-7.03M |
|
$-7.05M |
|
$-7.05M |
|
$-7.05M |
|
$-7.05M |
|
$-8.02M |
|
$-7.92M |
|
36.30M |
|
36.30M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$69.53M |
|
$0.68M |
|
$3.93M |
|
$73.46M |
|
$10.61M |
|
-- |
|
$3.42M |
|
$14.03M |
|
$59.42M |
|
$59.30M |
|
$59.42M |
|
36.34M |
|
| Cash Flow Statement Financials | |
$-8.58M |
|
-- |
|
-- |
|
$59.72M |
|
|
End Cash |
$50.30M |
$-9.43M |
|
$1.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.56 |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
71.80% |
|
-150.29% |
|
-150.29% |
|
-- |
|
-131.68% |
|
-132.15% |
|
$-8.58M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.17 |
|
0.57 |
|
158.90 |
|
-11.87% |
|
-11.89% |
|
-9.60% |
|
-11.87% |
|
$1.64 |
|
$-0.24 |
|
$-0.24 |
|